CompanyGraph
Prestige Consumer Healthcare Inc.
PBH · NYSE Arca · United States
prestigebrands.comFinancials as of FY2026
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2.36B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.28: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.36BUSDvs all stocks (USD)
Trailing P/E
12.77xRevenue (TTM)
1.09BUSDvs all stocks (USD)
Profit Margin
17.48%Beta
0.3470xvs all stocks
52-Week Change
-33.93%vs all stocks
Market Capitalization
2.36BUSDvs all stocks (USD)
Enterprise Value
3.35BUSDvs all stocks (USD)
Trailing P/E
12.77xForward P/E
9.85xPEG Ratio
0.9919xPrice to Sales (TTM)
2.17xPrice to Book (MRQ)
1.25xEnterprise to Revenue
3.07xEnterprise to EBITDA
9.82xGross Margin
51.95%Profit Margin
17.48%Operating Margin
26.81%Return on Assets (TTM)
5.61%Return on Equity (TTM)
10.22%Revenue (TTM)
1.09BUSDvs all stocks (USD)
Revenue per Share (TTM)
22.47USDUpdated Jul 19, 2026Quarterly Revenue Growth
-5.00%Gross Profit (TTM)
605.91MUSDvs all stocks (USD)
EBITDA (TTM)
331.11MUSDvs all stocks (USD)
Net Income (TTM)
190.30MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
7.60%Operating Cash Flow (TTM)
257.63MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
192.76MUSDvs all stocks (USD)
Payout Ratio
0.00%Revenue
1.09BUSDFY2026 · Mar 31, 2026Cost of Goods Sold
493.13MUSDFY2026 · Mar 31, 2026Gross Profit
595.58MUSDFY2026 · Mar 31, 2026Operating Income
309.41MUSDvs all stocks (USD)
Pre-tax Income
257.50MUSDFY2026 · Mar 31, 2026Income Tax Expense
67.19MUSDFY2026 · Mar 31, 2026Net Income
190.30MUSDFY2026 · Mar 31, 2026EBIT
299.83MUSDFY2026 · Mar 31, 2026EBITDA (Income Statement)
331.11MUSDFY2026 · Mar 31, 2026Selling, General & Administrative
265.23MUSDFY2026 · Mar 31, 2026Non-operating Interest Expense
42.34MUSDFY2026 · Mar 31, 2026EPS (Basic)
3.93USDFY2026 · Mar 31, 2026EPS (Diluted)
3.91USDFY2026 · Mar 31, 2026Basic Shares Outstanding
48.46MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
48.46MSharesFY2026 · Mar 31, 2026Net Income from Continuing Operations
190.30MUSDFY2026 · Mar 31, 2026Operating Cash Flow
261.90MUSDFY2026 · Mar 31, 2026Free Cash Flow
250.72MUSDFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
63.87MUSDFY2026 · Mar 31, 2026Income Tax Paid
45.94MUSDFY2026 · Mar 31, 2026Interest Paid
43.84MUSDFY2026 · Mar 31, 2026Starting Profit (CF Statement)
190.30MUSDFY2026 · Mar 31, 2026Depreciation & Amortization
31.27MUSDFY2026 · Mar 31, 2026Deferred Taxes (CF)
22.70MUSDFY2026 · Mar 31, 2026Stock-based Compensation
10.84MUSDFY2026 · Mar 31, 2026Other Non-cash Items
19.98MUSDFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-3.69MUSDFY2026 · Mar 31, 2026Change in Accounts Payable (CF)
-151.00KUSDFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-9.35MUSDFY2026 · Mar 31, 2026Capital Expenditures
-11.18MUSDFY2026 · Mar 31, 2026Net Acquisitions
-123.74MUSDFY2026 · Mar 31, 2026Other Investing Activity
-1.93MUSDFY2026 · Mar 31, 2026Net Investing Cash Flow
-136.84MUSDFY2026 · Mar 31, 2026Long-term Debt Payments
-42.48MUSDFY2026 · Mar 31, 2026Net Short-term Debt Issuance
2.99MUSDFY2026 · Mar 31, 2026Common Stock Repurchase
-156.28MUSDFY2026 · Mar 31, 2026Other Financing Charges
-4.57MUSDFY2026 · Mar 31, 2026Net Financing Cash Flow
-200.35MUSDFY2026 · Mar 31, 2026Shares Outstanding
47.32MSharesUpdated Jul 19, 2026Float Shares
46.69MSharesUpdated Jul 19, 2026Shares Short
3.21MSharesUpdated Jul 19, 2026Short Ratio
4.18daysvs all stocks
Short % of Shares Outstanding
8.18%vs all stocks
% Held by Insiders
1.38%vs all stocks
% Held by Institutions
113.92%vs all stocks
Total Cash (MRQ)
63.87MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.35USDUpdated Jul 19, 2026Total Debt (MRQ)
1.05BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.5539xCurrent Ratio (MRQ)
3.57xBook Value per Share (MRQ)
39.89USDUpdated Jul 19, 2026Total Assets
3.49BUSDvs all stocks (USD)
Total Current Assets
431.48MUSDFY2026 · Mar 31, 2026Total Liabilities
1.61BUSDFY2026 · Mar 31, 2026Total Non-current Assets
3.06BUSDFY2026 · Mar 31, 2026Total Non-current Liabilities
1.49BUSDFY2026 · Mar 31, 2026Total Current Liabilities
120.92MUSDFY2026 · Mar 31, 2026Cash & Cash Equivalents
63.87MUSDFY2026 · Mar 31, 2026Accounts Receivable
208.57MUSDFY2026 · Mar 31, 2026Inventory
159.13MUSDFY2026 · Mar 31, 2026Accounts Payable
22.79MUSDFY2026 · Mar 31, 2026Short-term Debt
12.55MUSDFY2026 · Mar 31, 2026Long-term Debt
1.03BUSDFY2026 · Mar 31, 2026Other Non-current Liabilities
5.58MUSDFY2026 · Mar 31, 2026Common Stock (Book)
562.00KUSDFY2026 · Mar 31, 2026Retained Earnings
1.75BUSDFY2026 · Mar 31, 2026Total Shareholders' Equity
1.89BUSDvs all stocks (USD)
Treasury Stock
439.30MUSDFY2026 · Mar 31, 202652-Week Low
42.62USDUpdated Jul 19, 202652-Week High
77.45USDUpdated Jul 19, 202652-Week Change
-33.93%vs all stocks
Beta
0.3470xvs all stocks
50-Day MA
48.24USDUpdated Jul 19, 2026200-Day MA
58.56USDUpdated Jul 19, 2026Avg 10-Day Volume
442.38KSharesUpdated Jul 19, 2026Avg 30-Day Volume
652.69KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
3.91USDUpdated Jul 19, 2026Other Income / Expense
-9.57MUSDFY2026 · Mar 31, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.07Revenue Growth YoY: -0.05
Financial Health
Altman Z-Score 2.28: grey zoneSignificant
Altman Z-Score: 2.28
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2.36B, above the global median of $1.15BNotable
Market cap (USD): 2,364,818,526Global Median: 1,146,734,693.424
Revenue is $1.09B, above the global median of $520.53MNotable
Revenue (USD): 1,088,705,024Global Median: 520,528,949.311
Levered free cash flow is $192.76M, above the global median of $16.24MNotable
Levered free cash flow (USD): 192,759,744Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
BioCryst Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pell Bio-Med Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
BrightGene Bio-Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Vericel Corporation
Tier 1ProductionApproval-Gated PipelineRule
Mineralys Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nurix Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Biohaven Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nektar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Agios Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
The Clorox Company
1 interpretationReceivables Heavy and Growing
Concentra Group Holdings Inc.
1 interpretationReceivables Heavy and Growing
Coforge Limited
1 interpretationReceivables Heavy and Growing